Bristol-Myers Squibb Co.

Bristol‑Myers Squibb leads in oncology and immunology, with blockbuster drugs like Opdivo, Eliquis, Revlimid, and Breyanzi. A robust pipeline and worldwide distribution underpin growth.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 34,100
HQ: Princeton

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
BMY	Bristol-Myers Squibb Co. Cap: 112.1B \| P/E: 18.3	EQUITY	NYQ	USD	US1101221083	Active	📈